# Pharmacokinetic Infliximab Data in Pediatric Crohn's Disease

> **NCT05552287** · PHASE4 · RECRUITING · sponsor: **Erasmus Medical Center** · enrollment: 50 (estimated)

## Conditions studied

- Crohn Disease
- Child, Only
- Biologic; Inadequate

## Interventions

- **DRUG:** Infliximab

## Key facts

- **NCT ID:** NCT05552287
- **Lead sponsor:** Erasmus Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-02
- **Primary completion:** 2025-08
- **Final completion:** 2025-08
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05552287

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05552287, "Pharmacokinetic Infliximab Data in Pediatric Crohn's Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05552287. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*